Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
214.50
-1.60 (-0.74%)
At close: Mar 5, 2026
-1.11% (1Y)
| Market Cap | 190.14B |
| Revenue (ttm) | 81.95B |
| Net Income (ttm) | 25.95B |
| Shares Out | 886.45M |
| EPS (ttm) | 29.27 |
| PE Ratio | 7.33 |
| Forward PE | 6.65 |
| Dividend | 12.00 (5.59%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 334,034 |
| Average Volume | 856,869 |
| Open | 216.10 |
| Previous Close | 216.10 |
| Day's Range | 213.90 - 216.10 |
| 52-Week Range | 198.00 - 236.00 |
| Beta | 0.05 |
| RSI | 38.55 |
| Earnings Date | Apr 29, 2026 |